Personalis, Inc.

NASDAQ:PSNL

4.32 (USD) • At close November 7, 2024
Bedrijfsnaam Personalis, Inc.
Symbool PSNL
Munteenheid USD
Prijs 4.32
Beurswaarde 229,282,704
Dividendpercentage 0%
52-weken bereik 0.891 - 7.2
Industrie Diagnostics & Research
Sector Healthcare
CEO Mr. Christopher M. Hall
Website https://www.personalis.com

An error occurred while fetching data.

Over Personalis, Inc.

Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or plasma

Vergelijkbare Aandelen

Sanara MedTech Inc. logo

Sanara MedTech Inc.

SMTI

33.91 USD

Lyra Therapeutics, Inc. logo

Lyra Therapeutics, Inc.

LYRA

0.265 USD

MoonLake Immunotherapeutics logo

MoonLake Immunotherapeutics

MLTX

50.67 USD

Tactile Systems Technology, Inc. logo

Tactile Systems Technology, Inc.

TCMD

15.255 USD

Marinus Pharmaceuticals, Inc. logo

Marinus Pharmaceuticals, Inc.

MRNS

0.359 USD

Pliant Therapeutics, Inc. logo

Pliant Therapeutics, Inc.

PLRX

15.19 USD

DermTech, Inc. logo

DermTech, Inc.

DMTK

0.094 USD

Immunic, Inc. logo

Immunic, Inc.

IMUX

1.18 USD

Kronos Bio, Inc. logo

Kronos Bio, Inc.

KRON

0.9 USD

Rapid Micro Biosystems, Inc. logo

Rapid Micro Biosystems, Inc.

RPID

1.24 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)